Nitric oxide enhancement of melphalan-induced cytotoxicity
1997
Nitric Oxide Enhances Melphalan's Cancer-Killing Effects
publication
Evidence: moderate
Author Information
Author(s): JA Cook, MC Krishna, R Pacelli, W DeGraff, J Liebmann, JB Mitchell, A Russo, DA Wink
Primary Institution: National Cancer Institute
Hypothesis
Does nitric oxide enhance the cytotoxicity of melphalan in cancer cells?
Conclusion
Nitric oxide significantly enhances the cytotoxicity of melphalan in both V79 and MCF-7 cancer cells.
Supporting Evidence
- NO treatment resulted in a 50% reduction in survival for V79 cells.
- Melphalan cytotoxicity was enhanced by approximately 3.6-fold in V79 cells and 4.3-fold in MCF-7 cells with NO treatment.
- NO pretreatment resulted in a delayed entry into S phase and a G/M block for both V79 and MCF-7 cells.
- Melphalan uptake was increased by 33% after NO exposure in V79 cells.
Takeaway
Nitric oxide helps make a cancer drug called melphalan work better at killing cancer cells.
Methodology
Clonogenic assays were used to assess the effects of nitric oxide on melphalan-induced cytotoxicity in V79 and MCF-7 cells.
Limitations
The study primarily focused on two cell lines, which may limit the generalizability of the findings.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website